Neutra Corp.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $291.8K
- Price
- $0.0001
- % Change (Daily % change from the live per-ticker quote feed.)
- 0.00%
- Volume
- 172.5K
About
Neutra Corp. specializes in the research, development, and provision of hemp-derived nutraceuticals. Its product portfolio features items such as CBD-infused sports creams, in addition to a variety of other health and wellness goods. Established in 2011, the company is headquartered in Sugar Land, Texas.
Quick stats
Shares outstanding2.9B
Computed float2.9B
Float / shares99.3%
Key info
SectorHealthcare
IndustryBiotechnology
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001512886
Websitehttps://neutrainc.com
AI Summary
AI-generated1/4
minorneutraloperations update
Neutra Corp's Neutra Life Sciences Expands 2026 Industry Conference Schedule to Deepen Sponsor and CRO Relationships Across Its Site Network
Neutra Life Sciences, the clinical research SMO subsidiary of Neutra Corp (NTRR), expanded its 2026 conference schedule to five events, adding Partnership with Sites, DPharm, and Fall Clinical – Dermatology.
The outreach strategy is designed to put its multi-site network in front of the sponsors and CROs that decide where clinical trials are placed.
Separately, the Women's Health Care Center of Baytown site has started operations and is now enrolling patients in two indications — early pregnancy and breast cancer screening — after the partnership was announced in June 2026.
Red flags
- Promotional conference-attendance release with no revenue, bookings, or contracted trial awards disclosed
- Micro-cap OTC issuer; site activation impact unquantified